Axsome Therapeutics is a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) conditions. We deliver scientific breakthroughs by identifying critical gaps in care and develop differentiated products with a focus on novel mechanisms of action that enable meaningful advancements in patient outcomes. Our industry-leading neuroscience portfolio includes FDA-approved treatments for major depressive disorder, agitation associated with dementia due to Alzheimer’s disease, excessive daytime sleepiness associated with narcolepsy and obstructive sleep apnea, and migraine, as well as multiple novel product candidates addressing a broad range of serious neurological and psychiatric conditions that impact over 150 million people in the United States. Together, we are on a mission to solve some of the brain’s biggest problems so patients and their loved ones can flourish. For more information, please visit us at www.axsome.com and follow us on LinkedIn and X . About This Role Axsome Therapeutics is seeking a Senior Manager, Finance who will be responsible for the preparation of Axsome's external financial reporting, including its periodic SEC filings, the research and documentation of technical accounting matters affecting the Company's financial statements, supporting the design, improvement, and testing of internal controls under SOX 404 for areas under responsibility. The Senior Manager, Finance will play a central role in the quarterly and annual external reporting cycle, working with colleagues in finance and throughout the organization in the preparation of financial statements, including drafting, reviewing, and improving the quality of information provided to readers and stakeholders. The Senior Manager, Finance will be a trusted business partner across finance, legal, investor relations, and Axsome's internal and external audit partners. This role will report directly to the Senior Director, Finance. This role
Role overview
Job description
About Formation Bio Formation Bio is a tech and AI driven pharma company differentiated by radically more efficient drug development. Advancements in AI and drug discovery are creating more candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded in 2016 as TrialSpark Inc., has built technology platforms, processes, and capabilities to accelerate all aspects of drug development and clinical trials. Formation Bio partners, acquires, or in-licenses drugs from pharma companies, research organizations, and biotechs to develop programs past clinical proof of concept and beyond, ultimately helping to bring new medicines to patients. The company is backed by investors across pharma and tech, including a16z, Se
…What they are looking for
Skills & requirements
Qualification
Build capabilities and provide training across the Finance team to drive quality and effectiveness in Finance output Qualifications Required CPA Ten or more years of progressive accounting experience, including direct responsibility for preparing audited US GAAP financial statements and footnotes and for supporting an external audit
Department · Finance
Hiring company
Formation Bio
View the company profile, current openings and hiring details.
Related opportunities
Similar active roles
Relevant, currently active roles for this market.
$189K – $240K/yr
$195K – $245K/yr
From $235.6K/yr
🔔 Get job alerts
New Director, Financial Reporting jobs in New York, New York, United States, straight to your inbox.
No spam · Unsubscribe anytime